Winfield Associates’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$2.71M Sell
20,778
-3,312
-14% -$431K 0.98% 27
2021
Q4
$3.68M Sell
24,090
-950
-4% -$145K 1.22% 19
2021
Q3
$4.05M Sell
25,040
-310
-1% -$50.1K 1.5% 13
2021
Q2
$4.15M Sell
25,350
-862
-3% -$141K 1.53% 13
2021
Q1
$3.95M Buy
26,212
+897
+4% +$135K 1.61% 13
2020
Q4
$3.84M Buy
25,315
+147
+0.6% +$22.3K 1.62% 12
2020
Q3
$3.41M Buy
25,168
+1,416
+6% +$192K 1.62% 13
2020
Q2
$3.25M Buy
23,752
+9,165
+63% +$1.25M 1.66% 12
2020
Q1
$1.57M Buy
14,587
+220
+2% +$23.7K 0.99% 30
2019
Q4
$1.73M Sell
14,367
-1,710
-11% -$206K 0.8% 34
2019
Q3
$1.6M Sell
16,077
-5,415
-25% -$539K 0.78% 36
2019
Q2
$2.35M Sell
21,492
-2,700
-11% -$295K 1.22% 24
2019
Q1
$2.71M Sell
24,192
-1,975
-8% -$221K 1.44% 19
2018
Q4
$2.52M Sell
26,167
-3,073
-11% -$296K 1.54% 17
2018
Q3
$3.57M Sell
29,240
-602
-2% -$73.4K 1.76% 14
2018
Q2
$3.28M Sell
29,842
-4,765
-14% -$523K 1.76% 16
2018
Q1
$3.69M Sell
34,607
-525
-1% -$56K 1.99% 15
2017
Q4
$3.75M Sell
35,132
-8,605
-20% -$919K 1.9% 13
2017
Q3
$4.86M Sell
43,737
-1,470
-3% -$163K 2.56% 8
2017
Q2
$4.67M Sell
45,207
-1,275
-3% -$132K 2.58% 7
2017
Q1
$4.54M Sell
46,482
-8,055
-15% -$787K 2.58% 7
2016
Q4
$4.82M Sell
54,537
-5,505
-9% -$487K 2.96% 5
2016
Q3
$5.79M Sell
60,042
-1,386
-2% -$134K 3.64% 3
2016
Q2
$5.27M Sell
61,428
-4,350
-7% -$373K 3.44% 4
2016
Q1
$5.72M Sell
65,778
-11,400
-15% -$991K 3.88% 5
2015
Q4
$8.7M Sell
77,178
-900
-1% -$102K 5.83% 1
2015
Q3
$7.89M Buy
78,078
+2,088
+3% +$211K 5.9% 1
2015
Q2
$9.35M Sell
75,990
-45
-0.1% -$5.54K 6.4% 1
2015
Q1
$8.7M Sell
76,035
-2,115
-3% -$242K 6.1% 1
2014
Q4
$7.9M Sell
78,150
-369
-0.5% -$37.3K 5.81% 1
2014
Q3
$7.16M Buy
78,519
+2,400
+3% +$219K 5.33% 1
2014
Q2
$6.52M Sell
76,119
-7,476
-9% -$640K 4.73% 1
2014
Q1
$6.59M Buy
83,595
+2,565
+3% +$202K 5.44% 1
2013
Q4
$6.13M Buy
+81,030
New +$6.13M 5.04% 1